-
VOLUNTARY ANNOUNCEMENT - CLINICAL TRIAL NOTICE OF“HS-10382 TABLETS”2022-01-18
-
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 20212022-01-04
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO THE RESTRICTED SHARE UNIT SCHEME2021-12-31
-
VOLUNTARY ANNOUNCEMENT - CLINICAL TRIAL NOTICE OF“HS-10383 TABLETS”2021-12-28
-
Terms of Reference of the Nomination Committee of the Board2021-12-23
-
ESTABLISHMENT OF THE NOMINATION COMMITTEE AND APPOINTMENT OF COMMITTEE MEMBERS2021-12-23
-
VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF AMEILE IN FIRST LINE LOCALLY ADVANCED OR METASTATIC EGFR-MUTATED NON-SMALL CELL LUNG CANCER2021-12-16
-
VOLUNTARY ANNOUNCEMENT - CLINICAL TRIAL APPROVAL OF“IBREXAFUNGERP TABLETS”2021-12-15
-
VOLUNTARY ANNOUNCEMENT - LICENSING AGREEMENT WITH KEROS2021-12-13
-
VOLUNTARY ANNOUNCEMENT - INCLUSION OF“TENOFOVIR AMIBUFENAMIDE TABLET”IN THE NATIONAL REIMBUREMENT DRUG LIST2021-12-03
-
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 20212021-12-01
-
VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF“FULVESTRANT INJECTION”2021-11-19
